<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Evry_Economy"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Evry/Economy">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Evry/Economy&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Evry/Economy&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Evry/Economy&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Evry/Economy" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Evry/Economy</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P><TITLE>Iron coli project</TITLE></P><DIV id="header"><UL id="menu"><LI><A id="home-link" href="https://2013.igem.org/Team:Evry">Home</A></LI><LI><A id="project-link" href="https://2013.igem.org/Team:Evry/Project" title="Overview">Project</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_metabolism">Iron metabolism</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_diseases">Related diseases</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_FUR">Iron chelators</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Achievements">Achievements</A></LI><LI><A href="https://2013.igem.org/Team:Evry/References">References</A></LI></UL><LI><A id="team-link" href="https://2013.igem.org/Team:Evry/Team" title="Our team">Team</A></LI><LI><A href="https://igem.org/Team.cgi?id=1163" target="_blank">iGEM Profile</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Attributions">Attributions</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Collaborations">Collaborations</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Acknowledgement">Acknowledgement</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Press">Press</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Gallery">Photo gallery</A></LI><LI><A id="model-link" href="https://2013.igem.org/Team:Evry/Modeling" title="Overview">Model</A></LI><LI><A href="https://2013.igem.org/Team:Evry/flush_model">Flush treatment</A></LI><LI><A href="https://2013.igem.org/Team:Evry/ent_prod">Enterobactin production</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Metabolism_model">Genome scale</A></LI><LI><A href="https://2013.igem.org/Team:Evry/pop_scale">Population scale</A></LI><LI><A href="https://2013.igem.org/Team:Evry/LogisticFunctions">Logistic functions</A></LI><LI><A href="https://2013.igem.org/Team:Evry/ChemicalTools">Chemical reasoning</A></LI><LI><A href="https://2013.igem.org/Team:Evry/data_analysis">Plate Reader</A></LI><LI><A id="biology-link" href="https://2013.igem.org/Team:Evry/Biology" title="Overview">Biology</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Sensor">Sensor</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Inverter">Inverter</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Chelator">Chelator</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Results">Results</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice" title="Overview">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Expert_consultation">Consultation</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Patients_perceptions">Survey</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Seminar">Seminar</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Philosophy">Philosophy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Economy">Economy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Art">Art</A></LI><LI><A id="ref-link" href="https://2013.igem.org/Team:Evry/Pill_design">Capsule</A></LI><LI><A id="notebook-link" href="https://2013.igem.org/Team:Evry/Notebook" title="Notebook">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Primers">Primers</A></LI><LI><A id="spon-link" href="https://2013.igem.org/Team:Evry/Sponsors">Sponsors</A></LI></DIV><P><ASIDE><HEADER>Human Practice</HEADER><UL><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice">Overview</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Expert_consultation">Phase 1: Consultation</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Patients_perceptions">Phase 2: Survey</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Seminar">Phase 3: Seminar</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Philosophy">Phase 4: Philosophy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Safety">Phase 5: Safety</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Economy">Phase 6: Economy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Art">Art</A></LI></UL></ASIDE></P><DIV id="maincontainer_evry2013"><DIV id="mainTextcontainer"><H1>Economy</H1><P>This section presents an evaluation of the costs for the patient or the community of the treatment, and its possible profitability. All the data used for this evaluation are presented below.</P><H2>Treatment costs</H2><P>We first want to know how much will cost our capsule. We estimate that the anticipated <B>market price of 1 capsule of Iron-Coli 10 cent</B>. The relatively low market price of Iron-Coli capsule is due to the fact that it is easy to produce capsules with only one strand of bacteria.
Further more the market price of current probiotic capsules is between 6 and 35 cent.<A href="#Ref"><SUP><SMALL>1,2,3</SMALL></SUP></A>
Moreover the patients will have to take 3 capsules each day. So our <B>bacterial treatment price per patient and per year</B> will cost: 0.10 x 3 x 365 = <B>110 euros</B> (~151 $ on the 28/10/2013).</P><P>In France, according to Dr. Françoise Courtois (General Secretary of European Federation of Associations of Patients with Haemochromatosis), bloodletting is charged around 40 euros, but costs in reality around 60 euro. The French public welfare system takes charge of all the costs. If a bacterial treatment enables to save money, it will be a collective benefit. According to the presidents of patients' associations, the average number of bloodlettings per patient and per year is 5. The average cost of <B>bloodletting treatment per patient and per year in France</B> is around <B>300 euros</B> (~413 $).</P><P>We established with our flush model that our treatment will decrease by two the iron absorption and thus by two the number of bloodleting for a patient. So the <B>money saved per patient and per year</B> is (300/2)-110=<B>40 euros</B> (~55 $).
This does not take into account the costs of a missing half-day's work, or the costs and time of transport, etc. Thus, the <B>collective benefit could be even higher</B> !</P><H2>Treatment profitability</H2><P> We estimated the cost of the lab' made capsule prototype around <B>3 cents</B>. According to the presidents of patients' associations, there are around <B>100 000 patients in France</B>, and <B>750 000 in Europe</B>.
Thus we could establish the profitability of our treatment in both France and Europe.</P><TABLE cellpadding="10" cellspacing="0" align="center" border="1"><THEAD><TR><TH align="center">
    France
   </TH><TH align="center">
    Europe
   </TH></TR></THEAD><TBODY><TR><TD align="center">
    Annual production costs
   </TD><TD align="center">
    100 000 x 0,03 x 3 x 365
    <B>~3,3 millions euros</B>
(~4,5 millions $)
   </TD><TD align="center">
    750 000 x 0,03 x 3 x 365
    <B>~25 millions euros</B>
(~34,5 millions $)
   </TD></TR><TR><TD align="center">
    Annual income
   </TD><TD align="center">
    100 000 x 0,1 x 3 x 365
    <B>~11 millions euros</B>
(~15 millions $)

   </TD><TD align="center">
    750 000 x 0,1 x 3 x 365
    <B>~82 millions euros</B>
(~113 millions $)
   </TD></TR><TR><TD align="center"><B>Annual profits</B>(annual income - annual production costs)
   </TD><TD align="center"><B>7,7 millions euros</B>
(~10,5 millions $)
   </TD><TD align="center"><B>57 millions euros</B>
(~78,5 millions $)
   </TD></TR></TBODY></TABLE><H2>Conclusions</H2><P>Our treatment will be benetial for both patients, community and pharmaceutical industries !
Further more, we did not into account other iron overload diseases as thalassemia; the benefitial and the profitability could be even higher !</P><DIV id="citation_box"><P id="references"><B>References:</B></P><OL><LI><A href="http://www.dieti-natura.com/bacteries-lactiques-1104.html?gclid=CPnO9P6WuboCFWfLtAod-ScAsw)" target="‘_blank'">http://www.dieti-natura.com/bacteries-lactiques-1104.html</A></LI><LI><A href="http://www.cocooncenter.com/Arkopharma-Azinc-Adultes-Probiotiques-30-Comprimes_9129.html?gclid=CIG-pp2ZuboCFe7HtAod3lYA0w)" target="‘_blank'">http://www.cocooncenter.com/Arkopharma-Azinc-Adultes-Probiotiques-30-Comprimes_9129.html</A></LI><LI><A href="http://www.fleurancenature.fr/complexe-ferments-lactiques.html?origine=L1&amp;mkwid=sMNlWLy44_dc&amp;pcrid=25236698593&amp;kword=probiotiques&amp;match=e&amp;plid=&amp;ectrans=1&amp;gclid=CPukz9WXuboCFWfLtAod-ScAsw&amp;xts=480830&amp;xtor=SEC-2-GOO-[]-[]-S-[probiotiques]&amp;xtdt=23049191)" target="‘_blank'">http://www.fleurancenature.fr/complexe-ferments-lactiques.html</A></LI></OL></DIV></DIV></DIV><DIV id="footer-wrapper"><DIV id="footer"><DIV>Contact: <A href="mailto:igemevry@gmail.com">igemevry@gmail.com</A></DIV></DIV><DIV align="center" style="font-size:60%">Site developped by Gabriel Guillocheau</DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Evry/Economy">http://2013.igem.org/Team:Evry/Economy</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Evry/Economy" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Evry/Economy" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Evry/Economy&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Evry/Economy&amp;oldid=358004" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>